Company intelligence / Profile preview

Centre for Novostics

Shatin, N.T., Hong Kongpmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

The Centre has successfully translated research on fetal DNA in maternal plasma into non-invasive prenatal tests now used clinically. Its EBV-DNA test for nasopharyngeal carcinoma was validated as a life-saving tool. Ongoing work includes expanding liquid biopsy applications to other cancers and diseases.

Therapeutic areas: OncologyImmunologyWomen's Health
Modalities: DNA testLiquid biopsy (diagnostic modality)Molecular diagnostics (platform/approach)Cell-free nucleic acid analysis
Industry: Molecular Diagnostics

Partnerships

InnoHK initiative (Hong Kong SAR Government and CUHK)

Beyond the preview

Go deeper on Centre for Novostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centre for Novostics.

Explore the full profile